Perceptive Advisors as of Sept. 30, 2023
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 95 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 11.1 | $337M | 28M | 12.16 | |
| Cerevel Therapeutics Hldng I (CERE) | 7.2 | $220M | 10M | 21.83 | |
| Immunovant (IMVT) | 4.8 | $146M | 3.8M | 38.39 | |
| Arcellx Common Stock (ACLX) | 4.7 | $142M | 4.0M | 35.88 | |
| Akero Therapeutics (AKRO) | 4.0 | $122M | 2.4M | 50.58 | |
| Nuvalent Inc-a (NUVL) | 3.7 | $113M | 2.5M | 45.97 | |
| Soleno Therapeutics (SLNO) | 3.0 | $91M | 3.1M | 29.51 | |
| Lianbio Sponsored Ads (LIANY) | 2.8 | $86M | 58M | 1.49 | |
| Inhibrx | 2.6 | $78M | 4.3M | 18.35 | |
| Aldeyra Therapeutics (ALDX) | 2.5 | $76M | 11M | 6.68 | |
| Argenx Se Sponsored Adr (ARGX) | 2.4 | $74M | 151k | 491.63 | |
| Vaxcyte (PCVX) | 2.3 | $69M | 1.3M | 50.98 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.1 | $65M | 4.0M | 16.30 | |
| Cymabay Therapeutics | 2.0 | $60M | 4.0M | 14.91 | |
| Meiragtx Holdings (MGTX) | 1.8 | $56M | 11M | 4.91 | |
| Iovance Biotherapeutics (IOVA) | 1.8 | $54M | 12M | 4.55 | |
| Lyra Therapeutics | 1.6 | $50M | 13M | 3.91 | |
| Amylyx Pharmaceuticals (AMLX) | 1.6 | $49M | 2.7M | 18.31 | |
| Bridgebio Pharma (BBIO) | 1.5 | $46M | 1.7M | 26.37 | |
| Medtronic SHS (MDT) | 1.5 | $46M | 587k | 78.36 | |
| Roivant Sciences SHS (ROIV) | 1.5 | $45M | 3.8M | 11.68 | |
| Disc Medicine (IRON) | 1.4 | $42M | 896k | 46.98 | |
| Immatics SHS (IMTX) | 1.3 | $40M | 3.5M | 11.58 | |
| Apogee Therapeutics (APGE) | 1.3 | $39M | 1.8M | 21.30 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.2 | $38M | 1.3M | 29.74 | |
| Revolution Medicines (RVMD) | 1.2 | $37M | 1.3M | 27.68 | |
| Springworks Therapeutics (SWTX) | 1.2 | $35M | 1.5M | 23.12 | |
| Sarepta Therapeutics (SRPT) | 1.1 | $34M | 283k | 121.22 | |
| Axsome Therapeutics (AXSM) | 1.1 | $34M | 482k | 69.89 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.1 | $33M | 996k | 32.77 | |
| Rapt Therapeutics | 1.0 | $32M | 1.9M | 16.62 | |
| Rocket Pharmaceuticals (RCKT) | 1.0 | $31M | 1.5M | 20.49 | |
| Nautilus Biotechnology (NAUT) | 0.9 | $29M | 9.1M | 3.16 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.9 | $29M | 3.0M | 9.56 | |
| Tango Therapeutics (TNGX) | 0.9 | $27M | 2.4M | 11.26 | |
| Adma Biologics (ADMA) | 0.8 | $25M | 7.0M | 3.58 | |
| Treace Med Concepts (TMCI) | 0.8 | $24M | 1.8M | 13.11 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $23M | 1.3M | 17.77 | |
| Cogent Biosciences (COGT) | 0.7 | $23M | 2.3M | 9.75 | |
| Mirum Pharmaceuticals (MIRM) | 0.7 | $21M | 672k | 31.60 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.7 | $21M | 2.4M | 8.72 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $21M | 618k | 34.16 | |
| Verrica Pharmaceuticals | 0.6 | $20M | 5.0M | 3.88 | |
| Biohaven (BHVN) | 0.6 | $20M | 752k | 26.01 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $18M | 125k | 146.04 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $18M | 159k | 112.50 | |
| Protagonist Therapeutics (PTGX) | 0.6 | $18M | 1.1M | 16.68 | |
| Rayzebio | 0.6 | $17M | 777k | 22.20 | |
| Cabaletta Bio (CABA) | 0.6 | $17M | 1.1M | 15.22 | |
| Relay Therapeutics (RLAY) | 0.5 | $16M | 1.9M | 8.41 | |
| Astria Therapeutics (ATXS) | 0.5 | $16M | 2.2M | 7.46 | |
| Miragen Therapeutics (VRDN) | 0.5 | $16M | 1.0M | 15.34 | |
| CryoLife (AORT) | 0.5 | $14M | 931k | 15.16 | |
| Establishment Labs Holdings Ord (ESTA) | 0.4 | $14M | 278k | 49.07 | |
| Evolus (EOLS) | 0.4 | $14M | 1.5M | 9.14 | |
| Tactile Systems Technology, In (TCMD) | 0.3 | $9.9M | 707k | 14.05 | |
| Biomea Fusion (BMEA) | 0.3 | $9.9M | 716k | 13.76 | |
| Athira Pharma (ATHA) | 0.3 | $9.7M | 4.8M | 2.02 | |
| Natera (NTRA) | 0.3 | $9.7M | 218k | 44.25 | |
| Zymeworks Del (ZYME) | 0.3 | $9.2M | 1.4M | 6.34 | |
| Solid Biosciences Com New (SLDB) | 0.3 | $8.8M | 3.5M | 2.52 | |
| Rhythm Pharmaceuticals (RYTM) | 0.3 | $8.7M | 381k | 22.93 | |
| Caremax Com Cl A | 0.3 | $8.1M | 3.8M | 2.12 | |
| Prothena Corp SHS (PRTA) | 0.3 | $8.0M | 166k | 48.25 | |
| Outset Med | 0.2 | $7.2M | 662k | 10.88 | |
| Fusion Pharmaceuticals | 0.2 | $7.2M | 2.8M | 2.60 | |
| Landos Biopharma Com New | 0.2 | $5.8M | 1.5M | 3.88 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $5.4M | 1.1M | 5.03 | |
| Tyra Biosciences (TYRA) | 0.2 | $5.0M | 360k | 13.77 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.2 | $4.9M | 555k | 8.75 | |
| Axogen (AXGN) | 0.1 | $4.4M | 876k | 5.00 | |
| Envveno Medical (NVNO) | 0.1 | $4.2M | 782k | 5.39 | |
| X4 Pharmaceuticals | 0.1 | $3.9M | 3.5M | 1.09 | |
| Novavax Com New Put Option (NVAX) | 0.1 | $3.8M | 1.3M | 2.90 | |
| Somalogic Class A Com | 0.1 | $3.6M | 1.5M | 2.39 | |
| Travere Therapeutics (TVTX) | 0.1 | $3.6M | 400k | 8.94 | |
| Point Biopharma Global Put Option | 0.1 | $2.6M | 800k | 3.29 | |
| Arcutis Biotherapeutics Put Option (ARQT) | 0.1 | $2.6M | 300k | 8.74 | |
| Eyepoint Pharmaceuticals Com New Put Option (EYPT) | 0.1 | $2.5M | 750k | 3.35 | |
| Kronos Bio | 0.1 | $2.3M | 1.8M | 1.30 | |
| Forte Biosciences | 0.1 | $2.2M | 3.3M | 0.66 | |
| Acelyrin | 0.1 | $2.0M | 200k | 10.17 | |
| 89bio Call Option (ETNB) | 0.1 | $1.6M | 400k | 4.05 | |
| Aclaris Therapeutics Put Option (ACRS) | 0.0 | $1.5M | 500k | 2.90 | |
| Aeglea Biotherapeutics Com New (SYRE) | 0.0 | $994k | 81k | 12.25 | |
| Vbi Vaccines Inc Cda Com New (VBIVQ) | 0.0 | $926k | 1.4M | 0.67 | |
| Singular Genomics Systems In | 0.0 | $900k | 2.4M | 0.38 | |
| Female Health (VERU) | 0.0 | $784k | 1.1M | 0.72 | |
| Viking Therapeutics Call Option (VKTX) | 0.0 | $240k | 300k | 0.80 | |
| Apellis Pharmaceuticals Put Option (APLS) | 0.0 | $73k | 100k | 0.72 | |
| Leap Therapeutics Com New (LPTX) | 0.0 | $62k | 45k | 1.38 | |
| Motus Gi Hldgs Com New | 0.0 | $41k | 90k | 0.45 | |
| Caremax *w Exp 06/08/202 | 0.0 | $11k | 60k | 0.19 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $10k | 250k | 0.04 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $6.7k | 167k | 0.04 |
